Efficacy and safety of miniscalpel acupuncture in Knee Degenerative Osteoarthritis Patients

Efficacy and safety of miniscalpel acupuncture in Knee Degenerative Osteoarthritis Patients (Pilot Study)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001899

Enrollment

Registered

2016-04-26

Start date

2016-03-07

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The experimental group will receive miniscapel acupuncture, and the control group will receive acupuncture and electroacupuncture. Miniscapel acupuncture is to recover the kinetic st

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 40–80 years 2. Diagnosed with osteoarthritis by American College of Rheumatology criteria(ACR criteria) 3. Subject who had hold their medication 1 weak ago, if subject take medication about osteoarthritis. 4. Subject who take part in this clinical trial by the will of themselves or the will of their guardian's. 5. Kellgren-Lawrence grade from 2 to 4 in knee X-ray test.

Exclusion criteria

Exclusion criteria: 1. Previous knee surgery because of osteoarthritis or other traumatic reseaon. 2. Subject who received intraarticular injection(steroid or Hyaluronic acid) or Prolotherapy in the past three months. 3. Psychiatric disorder, immune disorder patients or medications. 4. Subject who need steroid or Nonsteroidal antiinflammatory medication to treat other disease. 5. Post-traumatic osteoarthritis 6. Allergic skin disease, skin ulcer, skin infection. 7. Pregnancy, lactation, or planned pregnancy 8. Diabetic administered insulin, brain, cardiovascular disease, renal disease 9. Thrombolitic drugs, antiplatelet drug, anticoagulant medication 10. Abnormal finding on renal or hepatic function blood test 11. Subject inserting pacemaker 12. Subject who are deemed to unsuitable for experiments

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale(VAS);Range of motion(ROM)	—

Secondary

Measure	Time frame
Short-Form McGill Pain Questionnaire(SF-MPQ);Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC);Blood test and biochemistry test(Red Blood Cell, White Blood Cell, Haemoglobin, Hematocrit, Differential Count, Erythrocyte Sedimentation Rate, platelet, Aspartat aminotransferase, Alanine aminotransferase, Blood Urea Nitrogen, Creatinine, Sodium, Potassium, Chloride, Prothrombin Time, Partial Thromboplastin Time, C-Reactive Protein)	—

Measure

Time frame

Short-Form McGill Pain Questionnaire(SF-MPQ);Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC);Blood test and biochemistry test(Red Blood Cell, White Blood Cell, Haemoglobin, Hematocrit, Differential Count, Erythrocyte Sedimentation Rate, platelet, Aspartat aminotransferase, Alanine aminotransferase, Blood Urea Nitrogen, Creatinine, Sodium, Potassium, Chloride, Prothrombin Time, Partial Thromboplastin Time, C-Reactive Protein)

—

Countries

Korea, Republic of

Contacts

Public ContactJae-soo Kim

Daegu Haany University

jaice@daum.net+82-53-770-2108

Outcome results